CYTOSORBENTS CORPORATION - COMMON STOCK

CytoSorbents Expands Global Footprint with Opening of New Regional Sales Subsidiary in Dubai

06 янв 2025 07:00:00 Источник Nasdaq GlobeNewswire

CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2024 Product Revenue

03 янв 2025 07:00:00 Источник Nasdaq GlobeNewswire

CytoSorbents Rights Offering Begins

23 дек 2024 07:00:00 Источник Nasdaq GlobeNewswire

CytoSorbents Announces Rights Offering

09 дек 2024 07:00:00 Источник Nasdaq GlobeNewswire

CytoSorbents to Participate at the Piper Sandler 36th Annual Healthcare Conference

26 ноя 2024 07:00:00 Источник Nasdaq GlobeNewswire

CytoSorbents And Converge Biotech Announce Strategic Partnership to Expand Sepsis and Critical Care Treatment with CytoSorb in India

11 ноя 2024 07:30:00 Источник Nasdaq GlobeNewswire

CytoSorbents Reports Third Quarter 2024 Financial and Operational Results

07 ноя 2024 16:05:02 Источник Nasdaq GlobeNewswire

CytoSorbents Submits Health Canada Medical Device License Application for DrugSorb-ATR Following MDSAP Certification

04 ноя 2024 07:00:00 Источник Nasdaq GlobeNewswire

FDA Accepts DrugSorb-ATR De Novo Application To Reduce the Severity of CABG-Related Bleeding Due to Ticagrelor and Initiates Substantive Review

22 окт 2024 07:00:00 Источник Nasdaq GlobeNewswire

CytoSorbents to Report Third Quarter 2024 Operating and Financial Results

17 окт 2024 07:00:00 Источник Nasdaq GlobeNewswire

CytoSorbents Submits DrugSorb-ATR Marketing Application to U.S. FDA to Reduce the Severity of Bleeding in Heart Bypass Surgery Patients on the Blood Thinner Ticagrelor and Provides Business Update

01 окт 2024 07:00:00 Источник Nasdaq GlobeNewswire

CytoSorbents to Present at the H.C. Wainwright 26ᵗʰ Annual Global Investment Conference

27 авг 2024 07:00:00 Источник Nasdaq GlobeNewswire

CytoSorbents Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

16 авг 2024 16:05:00 Источник Nasdaq GlobeNewswire

CytoSorbents Reports Second Quarter 2024 Financial and Operational Results

13 авг 2024 16:19:55 Источник Nasdaq GlobeNewswire

CytoSorbents Appoints Peter J. Mariani Chief Financial Officer

13 авг 2024 16:18:28 Источник Nasdaq GlobeNewswire

CytoSorbents to Report Second Quarter 2024 Operating and Financial Results

07 авг 2024 07:00:00 Источник Nasdaq GlobeNewswire

CytoSorbents Announces Compliance with Nasdaq Minimum Bid Price Requirement

01 авг 2024 07:00:00 Источник Nasdaq GlobeNewswire

CytoSorbents Unveils Newly Redesigned, Unified Company and Product Website

30 июл 2024 02:00:00 Источник Nasdaq GlobeNewswire

CytoSorbents Unveils Newly Redesigned, Unified Company and Product Website

29 июл 2024 08:00:00 Источник Nasdaq GlobeNewswire

CytoSorbents to Present at the Inaugural American Association of Physicians of Indian Origin (AAPI) World Health Congress

17 июл 2024 07:00:00 Источник Nasdaq GlobeNewswire